PMC10008953_01
Therapeutic interventions and platelet counts. The reference range is indicated by dotted lines. PRRT, peptide radioreceptor therapy.
fendo-14-1095815-g001.jpg
PMC10008953_01_fendo-14-1095815-g001.jpg
f1
Platelet count was 121 G/L ( Figure 1 ). Over the next three years, platelet counts were in the 217 to 679 G/L range without any specific treatment, followed by a rise to the current 736 G/L ( Figure 1 ).
Pancreatic tumour histology. Large well-circumscribed tumour (black X) adjacent to normal pancreas tissue (black star). The arrow points to the fibrotic capsule-like pushing border zone". The black circle contains one of the Langerhans islands. Hematoxylin and eosin stain, 200x magnification.
fendo-14-1095815-g002.jpg
PMC10008953_01_fendo-14-1095815-g002.jpg
f2
The abdominal lesion was surgically removed by distal pancreatectomy ( Figure2 ).
Therapeutic interventions, pregnancies and serum chromogranin-A levels. The reference range is indicated by dotted lines. Cg-A, chromogranin-A.
fendo-14-1095815-g003.jpg
PMC10008953_01_fendo-14-1095815-g003.jpg
f3
Serum CgA level returned to the normal range and remained low during the three-monthly controls ( Figure 3 ).
Whole-body somatostatin receptor imaging. (A): planar gamma camera images, anterior view, (B): abdominal SPECT/CT images, coronal view. Baseline: multiple spleen and focal liver metastases. After surgery: focal liver and peritoneal oligometastases. After PRRT: focal liver metastasis. 1 year restaging: focal liver metastasis, 6 years restaging: no visible metastasis. Metastases are black on planar and red on SPECT/CT images.
fendo-14-1095815-g004.jpg
PMC10008953_01_fendo-14-1095815-g004.jpg
f4